Detail infomation of NONHSAG004630.1--NONCODE

Detail infomation of NONHSAG004630.1

General info

NONCODE GENE ID	NONHSAG004630.1
Chromosome	chr1
Start Site	232254255
End Site	232322542
Strand	+
Length	5203
Assembly	hg19
Class	Linc;
Other Gene Versions	NONHSAG004630.2

Transcripts in Gene

NONCODE TRANSCRIPT ID

NONHSAT010200.1

NONHSAT010202.1

Expression Profile (Data Source:)

adipose	adrenal	brain	brain_R	breast	colon

foreskin	heart	heart_R	HLF_1	HLF_2	kidney

liver	liver_R	lung	lymphNode	ovary	placenta_R

prostate	skeltalMuscle	testes	testes_R	thyroid	whiteBloodCell

Exosome Expression Profile (Data Source: NCBI GEO)

Expression Profile (Data Source: Single Cell)

Conservation Info

Chordata
- Vertebrates
  - Manmals
    - Primates
      - Human
      - Chimp : N/A
      - Gorilla : N/A
      - Orangutan : N/A
      - Rhesus : N/A
    - Rodents
      - Mouse : N/A
      - Rat : N/A
    - Laurasiatheria
      - Pig : N/A
      - Cow : N/A
    - Opossum : N/A
    - Platypus : N/A
  - Birds
    - Chicken : N/A
- Actinopteryqii
  - Zebrafish : N/A

Note: T = There are transcripts in this region.

Disease related

Disease:

NONCODE ID	Gene Symbol	Disease name	Source Database	Source PMID
NONHSAG004630.2	DISC1	schizophrenia		15478311
NONHSAG004630.2	DISC1	schizophrenia		17912248
NONHSAG004630.2	DISC1	schizophrenia		10814723

Mutations:

NONCODE ID	SNP ID	GWAS trait	Source PMID
NONHSAG004630.2	rs12082249	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs12082249	Lung function, ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	20010835
NONHSAG004630.2	rs9700757	Serum concentration of urate	21886157
NONHSAG004630.2	rs17832277	Gene expression of SIPA1L3 in peripheral blood monocytes	20502693
NONHSAG004630.2	rs12565588	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs12565588	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs12565588	Lung function, ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	20010835
NONHSAG004630.2	rs12565588	Serum concentration of taurochenodeoxycholate	21886157
NONHSAG004630.2	rs17832313	Maternal imprinting effects on cleft lip	22419666
NONHSAG004630.2	rs17832313	Lung function, ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	20010835
NONHSAG004630.2	rs867844	LDL cholesterol	20339536
NONHSAG004630.2	rs867844	LDL cholesterol change with statins	20339536
NONHSAG004630.2	rs867844	Lung function, predicted ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	19300500
NONHSAG004630.2	rs1888601	LDL cholesterol	20339536
NONHSAG004630.2	rs1888601	LDL cholesterol change with statins	20339536
NONHSAG004630.2	rs1888601	Lung function, predicted ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	19300500
NONHSAG004630.2	rs11122430	Longevity	21418511
NONHSAG004630.2	rs11122430	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs11122430	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs11122430	Longevity (males)	21418511
NONHSAG004630.2	rs11122430	Longevity (females)	21418511
NONHSAG004630.2	rs1331046	Serum ratio of (deoxycholate)/(taurocholate)	21886157
NONHSAG004630.2	rs11122431	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs11122431	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs11122432	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs11122432	Maternal transmission distortion	22377632
NONHSAG004630.2	rs11122432	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs11122432	Serum concentration of taurochenodeoxycholate	21886157
NONHSAG004630.2	rs11122432	Multiple complex diseases	17554300
NONHSAG004630.2	rs11122432	Hypertension, gender differentiated	17554300
NONHSAG004630.2	rs11122432	Lung function, ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	20010835
NONHSAG004630.2	rs11122432	Transmission distortion	22377632
NONHSAG004630.2	rs10864720	Serum ratio of (lathosterol)/(theobromine)	21886157
NONHSAG004630.2	rs10864720	LDL cholesterol	20339536
NONHSAG004630.2	rs10864720	LDL cholesterol change with statins	20339536
NONHSAG004630.2	rs10864720	Lung function, predicted ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	19300500
NONHSAG004630.2	rs12723746	Lung function, ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	20010835
NONHSAG004630.2	rs12563512	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs12563512	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs12563512	Lung function, ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	20010835
NONHSAG004630.2	rs11122433	Serum ratio of (glutamine)/(methionine)	21886157
NONHSAG004630.2	rs12039526	LDL cholesterol change with statins	20339536
NONHSAG004630.2	rs12039526	LDL cholesterol	20339536
NONHSAG004630.2	rs12039526	Lung function, predicted ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	19300500
NONHSAG004630.2	rs16856484	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs16856484	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs16856484	Lung function, ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	20010835
NONHSAG004630.2	rs16856487	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs16856487	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs12084949	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs12084949	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs11122434	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs11122434	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs10864721	N-terminal signal peptide of pro-B-type natriuretic peptide blood level	21273288
NONHSAG004630.2	rs10864721	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs10864721	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs9661921	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs9661921	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs9662635	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs9662635	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs12076041	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs12076041	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs12072521	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs12072521	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs12072521	Lung function, ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	20010835
NONHSAG004630.2	rs9793459	Serum ratio of (4-acetamidobutanoate)/(pipecolate)	21886157
NONHSAG004630.2	rs16856502	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs16856502	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs16856502	Lung function, ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	20010835
NONHSAG004630.2	rs12080088	Longevity	21418511
NONHSAG004630.2	rs12080088	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs12080088	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs12080088	Lung function, ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	20010835
NONHSAG004630.2	rs12080088	Longevity (males)	21418511
NONHSAG004630.2	rs9662589	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs9662589	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs9662589	Longevity	21418511
NONHSAG004630.2	rs9662589	Lung function, ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	20010835
NONHSAG004630.2	rs9662589	Hypertension, gender differentiated	17554300
NONHSAG004630.2	rs9662589	Multiple complex diseases	17554300
NONHSAG004630.2	rs9662589	Longevity (males)	21418511
NONHSAG004630.2	rs9662589	Decrease in FEV1 (in asthmatic ever smokers)	22424883
NONHSAG004630.2	rs9662895	Gene expression of HIST1H2AM in peripheral blood monocytes	20502693
NONHSAG004630.2	rs9662895	Serum ratio of (androsterone sulfate)/(sebacate (decanedioate))	21886157
NONHSAG004630.2	rs2183641	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs2183641	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs2183641	Lung function, ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	20010835
NONHSAG004630.2	rs2150552	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs2150552	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs2150552	Lung function, ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	20010835
NONHSAG004630.2	rs2150553	Decrease in FEV1 (in asthmatic participants)	22424883
NONHSAG004630.2	rs2150553	Lung function, forced expiratory volume in 1 second (FEV1) percent predicted (in asthmatic participants)	22424883
NONHSAG004630.2	rs2150553	Lung function, ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	20010835
NONHSAG004630.2	rs12087592	Serum ratio of (glutamine)/(methionine)	21886157
NONHSAG004630.2	rs2065347	Gene expression of SIPA1L3 in peripheral blood monocytes	20502693
NONHSAG004630.2	rs2065347	Serum concentration of phenylalanine	21886157
NONHSAG004630.2	rs1041469	Serum ratio of (androsterone sulfate)/(sebacate (decanedioate))	21886157
NONHSAG004630.2	rs1571750	Gene expression of NR2E1 in peripheral blood monocytes	20502693
NONHSAG004630.2	rs1571750	Serum concentration of theobromine	21886157
NONHSAG004630.2	rs1571751	Gene expression of NR2E1 in peripheral blood monocytes	20502693
NONHSAG004630.2	rs1571751	Serum concentration of theobromine	21886157
NONHSAG004630.2	rs9793010	Lung function, ratio of forced expiratory volume in 1 second (FEV1) to forced vital capacity (FVC) (FEV1/FVC)	20010835
NONHSAG004630.2	rs11122437	Serum ratio of (gamma-tocopherol)/(glycerol 2-phosphate)	21886157
NONHSAG004630.2	rs16856552	Triglycerides	20686565
NONHSAG004630.2	rs17776641	Gene expression of NAT12 in peripheral blood monocytes	20502693
NONHSAG004630.2	rs17776641	Gene expression of HIF3A in peripheral blood monocytes	20502693
NONHSAG004630.2	rs17776641	Gene expression of ADRBK2 in peripheral blood monocytes	20502693
NONHSAG004630.2	rs17776641	Gene expression of NR2E1 in peripheral blood monocytes	20502693
NONHSAG004630.2	rs17776641	Serum concentration of theobromine	21886157
NONHSAG004630.2	rs9308490	SM (COOH) C18:0	19043545
NONHSAG004630.2	rs9308490	SM (COOH) C16:0	19043545
NONHSAG004630.2	rs9308491	Serum ratio of (alpha-hydroxyisovalerate)/(pipecolate)	21886157
NONHSAG004630.2	rs9727900	Gene expression of HIF3A in peripheral blood monocytes	20502693
NONHSAG004630.2	rs9727900	Weight	0
NONHSAG004630.2	rs16856587	Gene expression of NR2E1 in peripheral blood monocytes	20502693
NONHSAG004630.2	rs16856587	Gene expression of SEC23A in peripheral blood monocytes	20502693
NONHSAG004630.2	rs12068588	Gene expression of NR2E1 in peripheral blood monocytes	20502693
NONHSAG004630.2	rs12068588	Serum concentration of theobromine	21886157
NONHSAG004630.2	rs12754490	Bipolar disorder and schizophrenia	20889312
NONHSAG004630.2	rs11590255	Serum concentration of pyridoxate	21886157
NONHSAG004630.2	rs1571755	Serum concentration of n-Butyl Oleate	21886157
NONHSAG004630.2	rs1571755	Information processing speed (Speed factor)	21130836
NONHSAG004630.2	rs1109916	Serum ratio of (4-vinylphenol sulfate)/(dodecanedioate)	21886157
NONHSAG004630.2	rs1888602	Serum ratio of (glycine)/(n-Butyl Oleate)	21886157
NONHSAG004630.2	rs16856643	Body mass index (BMI)	21701570
NONHSAG004630.2	rs16856643	Body mass index (BMI) (nondiabetic subjects)	21701570
NONHSAG004630.2	rs2884064	Serum ratio of (biliverdin)/(taurolithocholate 3-sulfate)	21886157
NONHSAG004630.2	rs12746164	Serum ratio of (glycine)/(n-Butyl Oleate)	21886157
NONHSAG004630.2	rs16856660	Type 2 diabetes, Hypertension, Coronary artery disease (CAD), combined case analysis	17554300
NONHSAG004630.2	rs16856660	Multiple complex diseases	17554300

NONCODE

Introduce of NONCODE

Browse NONCODE

Search a gene/transcript

Statistics

Blast

Genome

ID Conversion

Download

Bio-tools

ncFANs

CNCI

lnc-GFP

lncRNA Analysis pipeline